Cuba has mobilized its medical corps around the world to distribute a new “wonder drug” that officials there say is capable of treating the new coronavirus despite the United States’ strict sanctions that continue to pressure the communist-run island.
The drug, called Interferon Alpha-2B Recombinant (IFNrec), is jointly developed by scientists from Cuba and China, where the coronavirus COVID-19 disease outbreak first emerged late last year. Already active in China since January, the Cuban Medical Brigades began deploying to dozens of nations, providing personnel and products such as its new anti-viral drug to battle the disease that has exceeded 400,000 confirmed cases across the globe. As of Tuesday, over 100,000 people have recovered from the infection and more than 18,000 have died.
Cuba first used advanced interferon techniques to treat dengue fever in the 1980s and later found success in using it to combat HIV, human papillomavirus, Hepatitis B, Hepatitis C and other diseases. The use of Interferon Alpha-2B Recombinant “prevents aggravation and complications in patients reaching that stage that ultimately can result in death,” Cuban biotech expert Luis Herrera Martinez said, according to a recent Yale University Press Blog feature written by the University of Glasgow’s Helen Yaffe. She called the treatment a potential “wonder drug” against the new coronavirus.
Yaffe, who recently authored a book on Cuba’s post-Soviet economic experience entitled We Are Cuba!, told Newsweek that she knew of at least 15 countries that have contacted Cuba to request the drug, along with “local mayors and hospital directors who are anxious to get hold of the Cuban anti-viral to meet the crisis.” Interferon Alpha-2B Recombinant has not been approved to treat COVID-19, but has been proven effective against viruses similar to it.Ads by scrollerads.com
It has been selected along with 30 other drugs to treat COVID-19 by China’s National Health Commission. The World Health Organization will be studying interferon-beta, along with three other drugs, to determine their effectiveness against the new coronavirus.